Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA
2023 · Hepatology · 30 citations
https://doi.org/10.1097/hep.0000000000000727
S
Shannon M. Vandriel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
412
Citations
10
h-index
10
i10-index
Shannon M. Vandriel is an academic researcher from University of Toronto. The author has contributed to research in topics: Pediatric Hepatobiliary Diseases and Treatments & Gallbladder and Bile Duct Disorders & Liver Disease Diagnosis and Treatment. The author has an h-index of 10, co-authored 24 publications.
ORCID: 0000-0001-7157-2063Papers by this author
worksMaralixibat Reduces Serum Bile Acids and Improves Cholestatic Pruritus in Adolescents With Alagille Syndrome
2025 · Liver International · 5 citations
https://doi.org/10.1111/liv.16201
Children with autoimmune hepatitis receiving standard-of-care therapy demonstrate long-term obesity and linear growth delay
2025 · Hepatology Communications · 0 citations
https://doi.org/10.1097/hc9.0000000000000624
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat